To further validate the effects of the SARS‐CoV‐2 spike protein on insulin sensitivity and the metabolic benefits of metformin, we employed a well‐established mouse model of diabetes (db/db mice; Figure S6A). This evidence concerns the gene INS and diabetes mellitus.